litlas
Log inCreate account

Fernando Cabanillas

Active 1977–2024

108
Papers
29,988
Citations
90
h-index
108
i10-index

Citations

Citations per year for Fernando Cabanillas1978: 2 citations1979: 5 citations1980: 6 citations1981: 2 citations1982: 16 citations1983: 16 citations1984: 8 citations1985: 26 citations1986: 38 citations1987: 35 citations1988: 52 citations1989: 72 citations1990: 75 citations1991: 83 citations1992: 54 citations1993: 69 citations1994: 83 citations1995: 76 citations1996: 62 citations1997: 86 citations1998: 119 citations1999: 118 citations2000: 193 citations2001: 215 citations2002: 232 citations2003: 314 citations2004: 267 citations2005: 282 citations2006: 265 citations2007: 278 citations2008: 278 citations2009: 258 citations2010: 217 citations2011: 211 citations2012: 202 citations2013: 149 citations2014: 162 citations2015: 153 citations2016: 114 citations2017: 97 citations2018: 74 citations2019: 245 citations2020: 257 citations2021: 222 citations2022: 103 citations2023: 71 citations2024: 93 citations2025: 50 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,382 citing papers, 32% of this breakdownFrance: 502 citing papers, 6.7% of this breakdownUnited Kingdom: 498 citing papers, 6.7% of this breakdownGermany: 496 citing papers, 6.7% of this breakdownItaly: 443 citing papers, 6% of this breakdownCanada: 266 citing papers, 3.6% of this breakdownChina: 253 citing papers, 3.4% of this breakdownSpain: 225 citing papers, 3% of this breakdownSwitzerland: 222 citing papers, 3% of this breakdownJapan: 209 citing papers, 2.8% of this breakdownNetherlands: 196 citing papers, 2.6% of this breakdownAustralia: 194 citing papers, 2.6% of this breakdown
0%32%Other 20.9%

Institutions

Fields

  • Medicine85.3%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Immunology and Microbiology4.9%
  • Materials Science0.8%
  • Computer Science0.3%
  • Agricultural and Biological Sciences0.2%
  • Other1.1%

Topics

  • Lymphoma Diagnosis and Treatment20.1%
  • Viral-associated cancers and disorders6.4%
  • Chronic Lymphocytic Leukemia Research6.4%
  • CNS Lymphoma Diagnosis and Treatment5.4%
  • CAR-T cell therapy research3.6%
  • Cutaneous lymphoproliferative disorders research2.8%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    Authors: Bruce D. Cheson, Sandra J. Horning, B Coiffier, Margaret A. Shipp, Richard I. Fisher, Joseph M. Connors, Tim Lister, Julie M. Vose, Antonio J Grillo-López, Anton Hagenbeek, Fernando Cabanillas, Donald Klippensten, Wolfgang Hiddemann, Ronald A. Castellino, Nancy L. Harris, Jamés O. Armitage, William Carter, Richard T. Hoppe, George P. Canellos - Journal of Clinical Oncology 1999 cited by 3,490

  2. Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

    Authors: Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas, Myron S. Czuczman, Christos Emmanouilides, Robin Joyce, Brad Pohlman, Nancy L. Bartlett, Gregory A. Wiseman, Norman M. Padre, Antonio J Grillo-López, Pratik S. Multani, Christine A. White - Journal of Clinical Oncology 2002 cited by 1,166

  3. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

    Authors: Peter McLaughlin, A.J. Grillo-López, Brian K. Link, Ronald Levy, M. S. Czuczman, Michael E. Williams, Meyer R. Heyman, Isabelle Bence‐Bruckler, Christine A. White, Fernando Cabanillas, Vinay Jain, Anthony D. Ho, John Lister, Ken Wey, Diying Shen, B.K. Dallaire - Journal of Clinical Oncology 1998 cited by 2,759

  4. Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

    Authors: Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak, Liang Zhang, Fredrick Hagemeister, Sattva S. Neelapu, Felipe Samaniego, Peter McLaughlin, Michelle A. Fanale, Anas Younes, Fernando Cabanillas, Nathan Fowler, Kate J. Newberry, Luhong Sun, Ken H. Young, Richard E. Champlin, Larry W. Kwak, Lei Feng, Maria Badillo, Maria Teresa Bejarano, Kimberly Hartig, Wendy Chen, Yi‐Ming Chen, Catriona Byrne, Neda Bell, Jerome B. Zeldis, Jorge Romaguera - The Lancet Oncology 2012 cited by 297

  5. Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

    Authors: Deborah A. Thomas, Stefan Faderl, Susan O’Brien, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Guillermo Garcia‐Manero, Francis J. Giles, Srđan Verstovšek, William G. Wierda, Sherry Pierce, Jianqin Shan, Mark Brandt, Fredrick B. Hagemeister, Michael J. Keating, Fernando Cabanillas, Hagop M. Kantarjian - Cancer 2006 cited by 564

  6. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma

    Authors: Deborah A. Thomas, Susan O’Brien, Jörge E. Cortes, Francis J. Giles, Stefan Faderl, Srđan Verstovšek, Alessandra Ferrajoli, Charles Koller, Miloslav Beran, Sherry Pierce, Chul S. Ha, Fernando Cabanillas, Michael J. Keating, Hagop M. Kantarjian - Blood 2004 cited by 251

  7. A predictive model for aggressive non-Hodgkin's lymphoma

    Authors: Margaret A. Shipp, David P. Harrington, J R Anderson, Jamés O. Armitage, Gianni Bonadonna, G. Brittinger, Fernando Cabanillas, George P. Canellos, Bertrand Coiffier, Joseph M. Connors, Richard Cowan, D. Crowther, Steve Dahlberg, M. Engelhard, Richard I. Fisher, Christian Gisselbrecht, Sandra J. Horning, Éric Lepage, Tim Lister, J.H. Meerwaldt, E Montserrat, N. I. Nissen, Martin M. Oken, B. A. Peterson, Carlo Tondini, WS Velasquez, B.Y. Yeap - 1993 cited by 3,496

  8. High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

    Authors: Thierry Philip, Jamés O. Armitage, Gary Spitzer, Franck Chauvin, Sundar Jagannath, Jean‐Yves Cahn, Philippe Colombat, A H Goldstone, Norbert Claude Gorin, Michel Flesh, Jean-Philippe Laporte, D Maraninchi, J. L. Pico, André Bosly, Cathy M. Anderson, Rik Schots, Pierre Biron, Fernando Cabanillas, Karl Dicke - New England Journal of Medicine 1987 cited by 781

  9. Long-term results with radiotherapy for stage I–II follicular lymphomas

    Authors: Richard B. Wilder, Dan Jones, Susan L. Tucker, Lillian M. Fuller, Chul S Ha, Peter McLaughlin, Mark A. Hess, Fernando Cabanillas, James D. Cox - International Journal of Radiation Oncology*Biology*Physics 2001 cited by 179

  10. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

    Authors: A H Sarris, K. O. Kliche, P. Pethambaram, A. Preti, S. Tucker, Clotilde M. Jackow, Osvaldo Daniel Messina, William Pugh, Fredrick B. Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Jorge Romaguera, Herbert A. Fritsche, Thomas E. Witzig, Madeleine Duvic, M Andreeff, Fernando Cabanillas - Annals of Oncology 1999 cited by 163

  11. High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication

    Authors: Fernando Cabanillas, Idalia Liboy, Orestes Antonio Pavia, E. Rivera - Annals of Oncology 2006 cited by 82

  12. ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

    Authors: William S. Velasquez, Peter McLaughlin, S Tucker, Fredrick B. Hagemeister, F Swan, Maria Alma Rodriguez, Jorge Romaguera, Edward Rubenstein, Fernando Cabanillas - Journal of Clinical Oncology 1994 cited by 430

  13. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy

    Authors: Gregory M. Chronowski, Chul S. Ha, Richard B. Wilder, Fernando Cabanillas, John T. Manning, James D. Cox - Cancer 2001 cited by 318

  14. Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial

    Authors: Gideon Steinbach, R. Ford, Gary A. Glober, Dory Sample, Frederick Hagemeister, Patrick M. Lynch, Peter W. McLaughlin, Maria Alma Rodriguez, Jorge Romaguera, Andreas H. Sarris, Anas Younes, Rajyalakshmi Luthra, John T. Manning, Constance Johnson, Sandeep Lahoti, Yu Shen, Jeffrey E. Lee, Rodger J. Winn, Robert M. Genta, David Y. Graham, Fernando Cabanillas - Annals of Internal Medicine 1999 cited by 245

  15. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma.

    Authors: Sundar Jagannath, W S Velasquez, S.L. Tucker, Lillian M. Fuller, Peter W. McLaughlin, John T. Manning, L B North, Fernando Cabanillas - Journal of Clinical Oncology 1986 cited by 187

  16. Calcitriol Production in Hypercalcemic and Normocalcemic Patients with Non-Hodgkin Lymphoma

    Authors: John F. Seymour, Robert F. Gagel, Frederick Hagemeister, Meletios Α. Dimopoulos, Fernando Cabanillas - Annals of Internal Medicine 1994 cited by 144

  17. Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin’s Lymphoma and Hodgkin’s Disease

    Authors: Anas Younes, Barbara Pro, Michael J. Robertson, Ian W. Flinn, Jorge Romaguera, Fredrick B. Hagemeister, Nam H. Dang, Paolo Fiumara, Evelyne M. Loyer, Fernando Cabanillas, Peter W. McLaughlin, Maria Alma Rodriguez, Felipe Samaniego - Clinical Cancer Research 2004 cited by 107

  18. Differential Expression of BCL-2 Family Proteins in ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma of T/Null-Cell Lineage

    Authors: George Z. Rassidakis, Andreas H. Sarris, Marco Herling, R. Ford, Fernando Cabanillas, Timothy J. McDonnell, L. Jeffrey Medeiros - American Journal Of Pathology 2001 cited by 103

  19. Mantle-cell lymphoma

    Authors: İbrahim Barışta, Jorge Romaguera, Fernando Cabanillas - The Lancet Oncology 2001 cited by 98

  20. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

    Authors: Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak - Annals of Oncology 2009 cited by 88

  21. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

    Authors: WS Velasquez, Fernando Cabanillas, P. Salvador, Peter McLaughlin, Michael Fridrik, S Tucker, Sundar Jagannath, FB Hagemeister, JR Redman, F Swan - Blood 1988 cited by 581

  22. Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

    Authors: André Goy, Anas Younes, Peter McLaughlin, Barbara Pro, Jorge Romaguera, Frederick Hagemeister, Luis Fayad, Nam H. Dang, Felipe Samaniego, Michael Wang, Kristine Broglio, Barry I. Samuels, Frédéric Gilles, Andreas H. Sarris, Susan Hart, Elizabeth Trehu, David P. Schenkein, Fernando Cabanillas, Alma María Rodríguez - Journal of Clinical Oncology 2004 cited by 527

  23. Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Authors: Jordan U. Gutterman, George R. Blumenschein, Raymond Alexanian, Hwee‐Yong Yap, Aman U. Buzdar, Fernando Cabanillas, Gabriel N. Hortobágyi, Evan M. Hersh, Shelley L. Rasmussen, Maurice W. Harmon, Michael Kramer, Sidney Pestka - Annals of Internal Medicine 1980 cited by 505

  24. The Clinical Behavior of Localized and Multicentric Castleman Disease

    Authors: Juan Herrada, Fernando Cabanillas, Lawrence Rice, John T. Manning, William Pugh - Annals of Internal Medicine 1998 cited by 417